Latest filing published 15 Nov 2024 for Axonics, Inc., €2.3M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Karen Noblett (senior executive) discloses dealings in Axonics, Inc. to SEC (Form 4). The record holds 23 filings, for trades running from 23 July 2019 to 15 November 2024.
No open-market purchase appears, only 13 sales worth €6.7M. Besides market trades, the filings include 2 share grants and 7 option exercises. 2024 to date brings no purchases and 2 sales.
The record was last updated on 15 November 2024 with a transaction (€2.3M) in Axonics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations